首页 > 最新文献

Journal of the Chinese Medical Association : JCMA最新文献

英文 中文
The neuropsychological impacts of coronavirus disease 2019 in nonhospitalized patients with long coronavirus disease and brain fog. COVID-19 对长期 COVID 和脑雾的非住院患者的神经心理学影响。
Pub Date : 2025-01-01 Epub Date: 2024-10-01 DOI: 10.1097/JCMA.0000000000001175
Yu-Chen Chuang, Yu-Hsiang Cheng, Meng-Ju Tsai, Yi-Jiun Lu, Jong-Ling Fuh

Background: Coronavirus disease 2019 (COVID-19) causes persistent symptoms, including brain fog. Based on limited research on the long-term consequences of mild COVID-19, which has yielded inconsistent results, we investigated which cognitive functions were most affected by COVID-19 in nonhospitalized Asian patients with long-term COVID and subjective cognitive complaints.

Methods: Fifty-five nonhospitalized patients with subjective cognitive complaints after COVID infection (24 males and 31 females, mean age: 45.6 ± 14.6 years, mean duration of education: 14.4 ± 3.0 years) finished the study. Neuropsychological assessments included screening tests for overall cognition, and comprehensive tests for memory, executive function, processing speed, and subjective emotional and disease symptoms. Cognitive test scores were converted into Z -scores. Moreover, principal component analysis (PCA) was used to define cognitive domains across subtest scores.

Results: Comprehensive assessments revealed cognitive impairment in 69.1% of patients (<1.5 SD in at least one test). The processing speed (27.3%), memory recall (21.8%), memory learning (20.0%), and inhibitory control (18.2%) were the most affected areas. Self-reported anxiety and depression were observed in 35% and 33% of patients, respectively. Furthermore, the degree of anxiety was predictive of learning performance.

Conclusion: Nearly 70% of patients with subjective cognitive complaints and long COVID had objective cognitive impairments. A comprehensive evaluation is essential for these patients, even when they present with mild symptoms.

背景:冠状病毒病 2019(COVID-19)会导致包括脑雾在内的持续性症状。基于对轻度COVID-19长期后果的研究有限,且研究结果不一致,我们在非住院的亚洲长期COVID和主观认知症状患者中调查了COVID-19对哪些认知功能的影响最大:方法:55 名患有长期 COVID 和脑雾的非住院患者(男性 24 人,女性 31 人,平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年,平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年)。神经心理学评估包括总体认知筛选测试,以及记忆、执行功能、处理速度、主观情绪和疾病症状综合测试。认知测试得分被转换成 Z 分数。此外,还采用了主成分分析法(PCA)来界定不同子测试得分的认知领域:结果:综合评估显示,69.1% 的患者存在认知障碍(结论:近 70% 有主观症状的患者存在认知障碍):近 70% 有主观认知症状且 COVID 较长的患者存在客观认知障碍。对长期 COVID 和脑雾患者(包括症状轻微者)进行全面评估至关重要。
{"title":"The neuropsychological impacts of coronavirus disease 2019 in nonhospitalized patients with long coronavirus disease and brain fog.","authors":"Yu-Chen Chuang, Yu-Hsiang Cheng, Meng-Ju Tsai, Yi-Jiun Lu, Jong-Ling Fuh","doi":"10.1097/JCMA.0000000000001175","DOIUrl":"10.1097/JCMA.0000000000001175","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) causes persistent symptoms, including brain fog. Based on limited research on the long-term consequences of mild COVID-19, which has yielded inconsistent results, we investigated which cognitive functions were most affected by COVID-19 in nonhospitalized Asian patients with long-term COVID and subjective cognitive complaints.</p><p><strong>Methods: </strong>Fifty-five nonhospitalized patients with subjective cognitive complaints after COVID infection (24 males and 31 females, mean age: 45.6 ± 14.6 years, mean duration of education: 14.4 ± 3.0 years) finished the study. Neuropsychological assessments included screening tests for overall cognition, and comprehensive tests for memory, executive function, processing speed, and subjective emotional and disease symptoms. Cognitive test scores were converted into Z -scores. Moreover, principal component analysis (PCA) was used to define cognitive domains across subtest scores.</p><p><strong>Results: </strong>Comprehensive assessments revealed cognitive impairment in 69.1% of patients (<1.5 SD in at least one test). The processing speed (27.3%), memory recall (21.8%), memory learning (20.0%), and inhibitory control (18.2%) were the most affected areas. Self-reported anxiety and depression were observed in 35% and 33% of patients, respectively. Furthermore, the degree of anxiety was predictive of learning performance.</p><p><strong>Conclusion: </strong>Nearly 70% of patients with subjective cognitive complaints and long COVID had objective cognitive impairments. A comprehensive evaluation is essential for these patients, even when they present with mild symptoms.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"58-64"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancer. 依维莫司治疗转移性HR+/HER2-乳腺癌台湾队列的实际效果。
Pub Date : 2025-01-01 Epub Date: 2024-11-12 DOI: 10.1097/JCMA.0000000000001189
Yun-Chieh Kao, Yi-Fang Tsai, Shih-Che Shen, Ming-Shen Dai, Fang-Ming Chen, Liang-Chih Liu, Ta-Chung Chao, Chi-Cheng Huang, Ming-Feng Hou, Shin-Cheh Chen, Chun-Yu Liu, Ling-Ming Tseng

Background: Everolimus was the first orally targeted therapy for certain cancers. It was introduced before CDK4/6 inhibitors and is widely used to treat advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. This study presents comprehensive findings including updated data and long-term survival analyses focusing on patients with HR+/HER2- metastatic breast cancer who received everolimus-based treatment. The objectives were to assess the impact of everolimus on overall survival (OS) and progression-free survival (PFS) by treatment line, and to evaluate its role in therapeutic strategies in a real-world setting.

Methods: We included 299 women aged over 20 years with histologically confirmed HR+/HER2- breast cancer who received everolimus-based treatment from multiple medical centers in Taiwan. Survival curves were generated using the Kaplan-Meier method, with the log-rank test for comparisons. Univariate and multivariate analyses were performed using a Cox proportional hazards regression model. Adverse effects were graded according to the Common Terminology Criteria for Adverse Events version 5.0.

Results: The median PFS was 5.6 months, and the median OS was 60.1 months. Patients receiving everolimus treatment in three or more lines and those who underwent chemotherapy before everolimus-based treatment had a significantly shorter PFS but longer OS. Patients with liver and central nervous system metastases had significantly shorter PFS and OS. The disease control rate was 51.5%, and the overall response rate was 8.0%.

Conclusion: These findings support current guidelines and advocate for the inclusion of everolimus in treatment plans for patients with metastatic HR+/HER2- breast cancer, particularly in late-line treatment, with careful consideration of the benefit-risk profile for each patient.

背景依维莫司是第一种针对某些癌症的口服靶向疗法。它先于 CDK4/6 抑制剂问世,被广泛用于治疗晚期激素受体阳性(HR+)/人表皮生长因子受体 2 阴性(HER2-)乳腺癌。本研究针对接受依维莫司治疗的HR+/HER2-转移性乳腺癌患者进行了全面的研究,包括最新数据和长期生存分析。目的是评估依维莫司对各治疗线总生存期(OS)和无进展生存期(PFS)的影响,并评估其在现实世界中的治疗策略中的作用:我们纳入了299名年龄超过20岁、组织学确诊为HR+/HER2-乳腺癌、在台湾多家医疗中心接受依维莫司治疗的女性患者。采用 Kaplan-Meier 法绘制生存曲线,并用 log-rank 检验进行比较。采用Cox比例危险回归模型进行单变量和多变量分析。不良反应根据《不良事件通用术语标准》5.0版进行分级:中位PFS为5.6个月,中位OS为60.1个月。接受依维莫司三线或更多线治疗的患者以及在依维莫司治疗前接受化疗的患者的PFS明显较短,但OS较长。肝脏和中枢神经系统转移患者的PFS和OS明显较短。疾病控制率为51.5%,总体反应率为8.0%:这些研究结果支持现行指南,主张将依维莫司纳入转移性HR+/HER2-乳腺癌患者的治疗计划中,尤其是在晚期治疗中,同时仔细考虑每位患者的获益-风险情况。
{"title":"Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancer.","authors":"Yun-Chieh Kao, Yi-Fang Tsai, Shih-Che Shen, Ming-Shen Dai, Fang-Ming Chen, Liang-Chih Liu, Ta-Chung Chao, Chi-Cheng Huang, Ming-Feng Hou, Shin-Cheh Chen, Chun-Yu Liu, Ling-Ming Tseng","doi":"10.1097/JCMA.0000000000001189","DOIUrl":"10.1097/JCMA.0000000000001189","url":null,"abstract":"<p><strong>Background: </strong>Everolimus was the first orally targeted therapy for certain cancers. It was introduced before CDK4/6 inhibitors and is widely used to treat advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. This study presents comprehensive findings including updated data and long-term survival analyses focusing on patients with HR+/HER2- metastatic breast cancer who received everolimus-based treatment. The objectives were to assess the impact of everolimus on overall survival (OS) and progression-free survival (PFS) by treatment line, and to evaluate its role in therapeutic strategies in a real-world setting.</p><p><strong>Methods: </strong>We included 299 women aged over 20 years with histologically confirmed HR+/HER2- breast cancer who received everolimus-based treatment from multiple medical centers in Taiwan. Survival curves were generated using the Kaplan-Meier method, with the log-rank test for comparisons. Univariate and multivariate analyses were performed using a Cox proportional hazards regression model. Adverse effects were graded according to the Common Terminology Criteria for Adverse Events version 5.0.</p><p><strong>Results: </strong>The median PFS was 5.6 months, and the median OS was 60.1 months. Patients receiving everolimus treatment in three or more lines and those who underwent chemotherapy before everolimus-based treatment had a significantly shorter PFS but longer OS. Patients with liver and central nervous system metastases had significantly shorter PFS and OS. The disease control rate was 51.5%, and the overall response rate was 8.0%.</p><p><strong>Conclusion: </strong>These findings support current guidelines and advocate for the inclusion of everolimus in treatment plans for patients with metastatic HR+/HER2- breast cancer, particularly in late-line treatment, with careful consideration of the benefit-risk profile for each patient.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"26-33"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing sex-specific differences in sleep quality, resilience, and biomarkers among older adults in the Gan-Dau Healthy Longevity Plan. 分析赣鄱健康长寿计划中老年人在睡眠质量、恢复力和生物标志物方面的性别差异。
Pub Date : 2025-01-01 Epub Date: 2024-09-17 DOI: 10.1097/JCMA.0000000000001168
Fei-Yuan Hsiao, Zhi-Jun Chen, Heng-Hsin Tung, Sheng-Yuan Wang, Wei-Ju Lee, Chih-Kuang Liang, Liang-Kung Chen
<p><strong>Background: </strong>Limited knowledge exists regarding the interrelations between sleep quality and resilience within the demographic of healthy, community-residing middle-aged and older adults, with a particular dearth of information regarding sex-specific associations. This study aimed to examine the sex-specific associations between sleep quality, resilience, and biomarkers in community-dwelling middle-aged and older adults.</p><p><strong>Methods: </strong>This cross-sectional study was conducted using data from the 2022 Gan-Dau Healthy Longevity Plan survey initiated by the locality-based community hospital, Taipei Municipal Gan-Dau Hospital (TMGDH). A total of 770 participants (240 men, 530 women) who met the inclusion criteria were included in the study. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), while resilience was measured using the Brief Resilience Scale (BRS). Patient demographic data, including age, education, marital status, and depression level, were also collected. The sex-specific associations between sleep quality and resilience were first examined using multivariate generalized linear models (GLMs). In addition, the associations between sleep quality, resilience, and selected biomarkers were examined using multivariate GLMs.</p><p><strong>Results: </strong>Approximately 55% of men and 60% of women reported poor sleep quality. Individuals with good sleep quality had significantly lower levels of depressive symptoms ( p = 0.028 for men, p = 0.002 for women) and fewer chronic conditions ( p = 0.002 for men, p < 0.001 for women). Notably, women in the "poor sleep quality" group exhibited higher proportions of low habitual sleep efficiency (women 35.9% vs men 29.8%) and frequent use of sleeping medications (women 23.2% vs men 9.9%) than men. Good sleep quality was associated with better resilience in both men (mean BRS score: good sleep quality = 25.1 [SD: 4.3] vs poor sleep quality = 23.4 [SD: 4.7], p = 0.004) and women (mean BRS score: good sleep quality = 24.3 [SD: 5.1] vs poor sleep quality = 22.3 [SD: 5.4], p < 0.001). After adjusting for depressive symptoms and chronic conditions, this association remained significant for men ( p = 0.022) and women ( p = 0.001). In addition, greater depressive symptoms were associated with poorer resilience in both sexes ( p < 0.001). No significant associations were noted between sleep quality or resilience and the selected biomarkers.</p><p><strong>Conclusion: </strong>This study highlights the association between sleep quality and resilience in older adults. Good sleep quality is related to better resilience, but greater depressive symptoms are also linked to poorer resilience in both sexes. Nevertheless, the low habitual sleep efficiency and frequent use of sleeping medications in women but not men with poor sleep quality highlight the need to explore sex-specific approaches to address the interplay of sleep quality, resilience, and other factors
背景:对于健康、居住在社区的中老年人群中睡眠质量和恢复力之间的相互关系,人们所知有限,尤其是有关性别特异性关联的信息更是匮乏。本研究旨在探讨社区中老年人的睡眠质量、恢复力和生物标志物之间的性别特异性关联:这项横断面研究使用了由台北市立甘道医院(TMGDH)发起的 2022 年甘道健康长寿计划调查数据。研究共纳入了 770 名符合纳入标准的参与者(男性 240 人,女性 530 人)。睡眠质量采用匹兹堡睡眠质量指数(PSQI)进行评估,复原力则采用简易复原力量表(BRS)进行测量。研究还收集了患者的人口统计学数据,包括年龄、教育程度、婚姻状况和抑郁程度。首先使用多变量广义线性模型(GLMs)检验了睡眠质量和恢复力之间的性别特异性关联。此外,还使用多变量广义线性模型研究了睡眠质量、恢复力和选定生物标志物之间的关系:结果:约 55% 的男性和 60% 的女性报告睡眠质量不佳。睡眠质量好的人抑郁症状水平明显较低(男性 p=0.028,女性 p=0.028):这项研究强调了老年人睡眠质量与复原力之间的关系。良好的睡眠质量与较强的恢复能力有关,但抑郁症状较重也与男女两性较差的恢复能力有关。尽管如此,睡眠质量差的女性(而非男性)的习惯性睡眠效率较低,且经常使用安眠药物,这突出表明有必要探索针对不同性别的方法,以解决健康老龄化过程中睡眠质量、恢复力和其他人口因素(如抑郁症状)之间的相互作用问题。
{"title":"Analyzing sex-specific differences in sleep quality, resilience, and biomarkers among older adults in the Gan-Dau Healthy Longevity Plan.","authors":"Fei-Yuan Hsiao, Zhi-Jun Chen, Heng-Hsin Tung, Sheng-Yuan Wang, Wei-Ju Lee, Chih-Kuang Liang, Liang-Kung Chen","doi":"10.1097/JCMA.0000000000001168","DOIUrl":"10.1097/JCMA.0000000000001168","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Limited knowledge exists regarding the interrelations between sleep quality and resilience within the demographic of healthy, community-residing middle-aged and older adults, with a particular dearth of information regarding sex-specific associations. This study aimed to examine the sex-specific associations between sleep quality, resilience, and biomarkers in community-dwelling middle-aged and older adults.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This cross-sectional study was conducted using data from the 2022 Gan-Dau Healthy Longevity Plan survey initiated by the locality-based community hospital, Taipei Municipal Gan-Dau Hospital (TMGDH). A total of 770 participants (240 men, 530 women) who met the inclusion criteria were included in the study. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), while resilience was measured using the Brief Resilience Scale (BRS). Patient demographic data, including age, education, marital status, and depression level, were also collected. The sex-specific associations between sleep quality and resilience were first examined using multivariate generalized linear models (GLMs). In addition, the associations between sleep quality, resilience, and selected biomarkers were examined using multivariate GLMs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Approximately 55% of men and 60% of women reported poor sleep quality. Individuals with good sleep quality had significantly lower levels of depressive symptoms ( p = 0.028 for men, p = 0.002 for women) and fewer chronic conditions ( p = 0.002 for men, p &lt; 0.001 for women). Notably, women in the \"poor sleep quality\" group exhibited higher proportions of low habitual sleep efficiency (women 35.9% vs men 29.8%) and frequent use of sleeping medications (women 23.2% vs men 9.9%) than men. Good sleep quality was associated with better resilience in both men (mean BRS score: good sleep quality = 25.1 [SD: 4.3] vs poor sleep quality = 23.4 [SD: 4.7], p = 0.004) and women (mean BRS score: good sleep quality = 24.3 [SD: 5.1] vs poor sleep quality = 22.3 [SD: 5.4], p &lt; 0.001). After adjusting for depressive symptoms and chronic conditions, this association remained significant for men ( p = 0.022) and women ( p = 0.001). In addition, greater depressive symptoms were associated with poorer resilience in both sexes ( p &lt; 0.001). No significant associations were noted between sleep quality or resilience and the selected biomarkers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study highlights the association between sleep quality and resilience in older adults. Good sleep quality is related to better resilience, but greater depressive symptoms are also linked to poorer resilience in both sexes. Nevertheless, the low habitual sleep efficiency and frequent use of sleeping medications in women but not men with poor sleep quality highlight the need to explore sex-specific approaches to address the interplay of sleep quality, resilience, and other factors","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"15-25"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plate osteosynthesis of phalanx fractures using wide-awake local anesthesia no tourniquet technique is cost-effective and associated with less postoperative pain. 采用宽清醒局部麻醉无止血带技术对指骨骨折进行钢板骨合成术具有成本效益,且术后疼痛较轻。
Pub Date : 2025-01-01 Epub Date: 2024-09-24 DOI: 10.1097/JCMA.0000000000001174
Wei-Chieh Chen, Chun-Yu Chen, Yen-Chang Lin

Background: The wide-awake local anesthesia no tourniquet (WALANT) technique, which is based on the local infiltration of lidocaine and epinephrine, is widely used in hand and wrist surgery. However, few studies have been conducted on the cost-benefit analysis of phalanx fracture surgery using the WALANT technique. This study aimed to investigate the clinical condition, as well as the time spent for anesthesia and operation. We also performed an economic analysis to compare general anesthesia, local anesthesia with a tourniquet, and the WALANT technique for plate fixation of phalanx fractures.

Methods: This retrospective study included all patients with single phalanx fractures who underwent open reduction internal fixation with plating between January 2015 and December 2019. Patients were divided into three groups according to the anesthesia method: general anesthesia with a tourniquet (GA group), local anesthesia with a tourniquet (LA group), and the WALANT technique (WALANT group). Data, including demographics, anesthesia and surgical time, postoperative pain score, and vomiting ratio, were collected and analyzed.

Results: A total of 62 patients were included in this study. Of the 62 patients, 15 were included in the GA group, 32 in the LA group, and 15 in the WALANT group. No complications were reported during surgery or follow-up in any group. The GA group exhibited a significantly longer anesthesia time than the other two groups, with an average of 32.4 minutes. However, no significant difference in surgical time was observed among the three groups. The WALANT group exhibited a significantly lower postoperative day 1 pain score than the other two groups. The additional cost of general anesthesia was approximately 350 US dollars (USD), accounting for approximately one-third to one-fourth of the total expenses for phalanx surgery.

Conclusion: Open reduction with plate fixation of phalanx fractures using the WALANT technique or local anesthesia was cost-effective compared with general anesthesia. Patients who underwent phalanx fracture surgery using the WALANT technique experienced less pain on the first postoperative day because of the adequate tumescent technique and not using a tourniquet during surgery.

背景:宽醒局部麻醉无止血带(WALANT)技术以利多卡因和肾上腺素的局部浸润为基础,被广泛应用于手部和腕部手术。然而,有关使用 WALANT 技术进行指骨骨折手术的成本效益分析的研究却很少。本研究旨在调查临床状况、麻醉时间和手术时间。我们还对全身麻醉、止血带局部麻醉和 WALANT 技术用于指骨骨折钢板固定进行了经济性分析:这项回顾性研究纳入了2015年1月至2019年12月期间接受切开复位内固定加钢板固定术的所有单指骨骨折患者。根据麻醉方法将患者分为三组:带止血带的全身麻醉(GA组)、带止血带的局部麻醉(LA组)和WALANT技术(WALANT组)。收集和分析的数据包括人口统计学、麻醉和手术时间、术后疼痛评分和呕吐比例:结果:本研究共纳入 62 例患者。62名患者中,GA组15人,LA组32人,WALANT组15人。两组患者在手术和随访期间均未出现并发症。GA组的麻醉时间明显长于其他两组,平均为32.4分钟。不过,三组的手术时间没有明显差异。WALANT 组的术后疼痛评分明显低于其他两组。全身麻醉的额外费用约为 350 美元,约占趾骨手术总费用的三分之一到四分之一:结论:与全身麻醉相比,采用 WALANT 技术和局部麻醉对指骨骨折进行切开复位并用钢板固定具有成本效益。使用 WALANT 技术进行指骨骨折手术的患者在术后第一天的疼痛感比使用全身麻醉或局部麻醉加止血带进行手术的患者要轻,这是因为 WALANT 技术采用了充分的膨胀技术,而且在手术过程中没有使用止血带。
{"title":"Plate osteosynthesis of phalanx fractures using wide-awake local anesthesia no tourniquet technique is cost-effective and associated with less postoperative pain.","authors":"Wei-Chieh Chen, Chun-Yu Chen, Yen-Chang Lin","doi":"10.1097/JCMA.0000000000001174","DOIUrl":"10.1097/JCMA.0000000000001174","url":null,"abstract":"<p><strong>Background: </strong>The wide-awake local anesthesia no tourniquet (WALANT) technique, which is based on the local infiltration of lidocaine and epinephrine, is widely used in hand and wrist surgery. However, few studies have been conducted on the cost-benefit analysis of phalanx fracture surgery using the WALANT technique. This study aimed to investigate the clinical condition, as well as the time spent for anesthesia and operation. We also performed an economic analysis to compare general anesthesia, local anesthesia with a tourniquet, and the WALANT technique for plate fixation of phalanx fractures.</p><p><strong>Methods: </strong>This retrospective study included all patients with single phalanx fractures who underwent open reduction internal fixation with plating between January 2015 and December 2019. Patients were divided into three groups according to the anesthesia method: general anesthesia with a tourniquet (GA group), local anesthesia with a tourniquet (LA group), and the WALANT technique (WALANT group). Data, including demographics, anesthesia and surgical time, postoperative pain score, and vomiting ratio, were collected and analyzed.</p><p><strong>Results: </strong>A total of 62 patients were included in this study. Of the 62 patients, 15 were included in the GA group, 32 in the LA group, and 15 in the WALANT group. No complications were reported during surgery or follow-up in any group. The GA group exhibited a significantly longer anesthesia time than the other two groups, with an average of 32.4 minutes. However, no significant difference in surgical time was observed among the three groups. The WALANT group exhibited a significantly lower postoperative day 1 pain score than the other two groups. The additional cost of general anesthesia was approximately 350 US dollars (USD), accounting for approximately one-third to one-fourth of the total expenses for phalanx surgery.</p><p><strong>Conclusion: </strong>Open reduction with plate fixation of phalanx fractures using the WALANT technique or local anesthesia was cost-effective compared with general anesthesia. Patients who underwent phalanx fracture surgery using the WALANT technique experienced less pain on the first postoperative day because of the adequate tumescent technique and not using a tourniquet during surgery.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"80-84"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of round spermatid injection vs intracytoplasmic sperm injection: The role of hormonal pretreatment for nonobstructive azoospermia. 圆形精子注射与胞浆内精子注射的临床效果:激素预处理对男性非梗阻性无精子症患者的潜在作用。
Pub Date : 2025-01-01 Epub Date: 2024-10-24 DOI: 10.1097/JCMA.0000000000001184
Nai-Ming Cheng, William J Huang, Chen-Yu Huang, Yi-Jen Chen, Chi-Hong Ho

Background: Round spermatid injection (ROSI) into oocytes offers men with nonobstructive azoospermia (NOA) the opportunity to have biological offspring in cases where mature spermatozoa are not detected. However, the clinical outcomes of ROSI remain poor. This study compared the outcomes of ROSI with intracytoplasmic sperm injection (ICSI) and investigated the effect of hormonal pretreatment.

Methods: This retrospective cohort study enrolled infertile couples undergoing either ROSI or ICSI at the reproductive center in Taipei Veterans General Hospital. The administration of selective estrogen receptor modulators, gonadotropins, and aromatase inhibitors in male patients were recorded. Relevant hormonal markers and biochemical parameters were determined. The outcomes of ROSI and ICSI were assessed based on fertilization rate, implantation rate, and live birth rate.

Results: A total of 36 couples were recruited in the ROSI group, whereas 39 couples were recruited in the ICSI group for the analysis. Patients in each group demonstrated similar characteristics, except for a higher proportion of male patients in the ROSI group who were pretreated with anastrozole. The fertilization rate and implantation rate were similar between ROSI and ICSI groups after adjusting for confounding variables. The live birth rate was significantly lower in the ROSI group (8.3%) than in the ICSI group (30.8%) before and after adjusting for confounding variables.

Conclusion: ROSI demonstrated fertilization and implantation rates comparable to those of ICSI for male patient with NOA undergoing testicular sperm extraction surgery. Anastrozole may improve the outcomes of ROSI into oocytes. Further studies evaluating the effect of anastrozole administration on ROSI outcomes are warranted.

背景:向卵母细胞注入圆形精子(ROSI)为患有非梗阻性无精子症(NOA)的男性提供了在检测不到成熟精子的情况下生育后代的机会。然而,ROSI 的临床效果仍然不佳。本研究比较了ROSI与卵胞浆内单精子显微注射(ICSI)的疗效,并探讨了激素预处理的影响:这项回顾性队列研究招募了在台北荣民总医院生殖中心接受ROSI或ICSI的不育夫妇。收集了男性患者使用选择性雌激素受体调节剂、促性腺激素和芳香化酶抑制剂的情况。测定了相关激素标记物和生化参数。根据受精率、植入率和活产率评估了ROSI和ICSI的结果:ROSI组共招募了36对夫妇,而ICSI组招募了39对夫妇进行分析。除了ROSI组中使用阿那曲唑预处理的男性患者比例较高外,两组患者的特征相似。在对混杂变量进行调整后,ROSI 组和 ICSI 组的受精率和植入率相似。在调整混杂变量前后,ROSI组的活产率(8.3%)明显低于ICSI组(30.8%):结论:对于接受睾丸取精手术的无精子症男性患者,ROSI的受精率和植入率与ICSI相当。有必要进一步研究阿那曲唑用药对ROSI结果的影响。
{"title":"Clinical outcomes of round spermatid injection vs intracytoplasmic sperm injection: The role of hormonal pretreatment for nonobstructive azoospermia.","authors":"Nai-Ming Cheng, William J Huang, Chen-Yu Huang, Yi-Jen Chen, Chi-Hong Ho","doi":"10.1097/JCMA.0000000000001184","DOIUrl":"10.1097/JCMA.0000000000001184","url":null,"abstract":"<p><strong>Background: </strong>Round spermatid injection (ROSI) into oocytes offers men with nonobstructive azoospermia (NOA) the opportunity to have biological offspring in cases where mature spermatozoa are not detected. However, the clinical outcomes of ROSI remain poor. This study compared the outcomes of ROSI with intracytoplasmic sperm injection (ICSI) and investigated the effect of hormonal pretreatment.</p><p><strong>Methods: </strong>This retrospective cohort study enrolled infertile couples undergoing either ROSI or ICSI at the reproductive center in Taipei Veterans General Hospital. The administration of selective estrogen receptor modulators, gonadotropins, and aromatase inhibitors in male patients were recorded. Relevant hormonal markers and biochemical parameters were determined. The outcomes of ROSI and ICSI were assessed based on fertilization rate, implantation rate, and live birth rate.</p><p><strong>Results: </strong>A total of 36 couples were recruited in the ROSI group, whereas 39 couples were recruited in the ICSI group for the analysis. Patients in each group demonstrated similar characteristics, except for a higher proportion of male patients in the ROSI group who were pretreated with anastrozole. The fertilization rate and implantation rate were similar between ROSI and ICSI groups after adjusting for confounding variables. The live birth rate was significantly lower in the ROSI group (8.3%) than in the ICSI group (30.8%) before and after adjusting for confounding variables.</p><p><strong>Conclusion: </strong>ROSI demonstrated fertilization and implantation rates comparable to those of ICSI for male patient with NOA undergoing testicular sperm extraction surgery. Anastrozole may improve the outcomes of ROSI into oocytes. Further studies evaluating the effect of anastrozole administration on ROSI outcomes are warranted.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"52-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prediction model of echocardiographic variables to screen for potentially correctable shunts in adult atrial septal defect-pulmonary hypertension patients. 用于筛查成人 ASD-PAH 患者潜在可纠正分流的超声心动图变量预测模型。
Pub Date : 2025-01-01 Epub Date: 2024-11-11 DOI: 10.1097/JCMA.0000000000001190
He-Zhi Li, Song Wen, Ze-Han Huang, Hong-Wen Fei, Cao-Jin Zhang

Background: Atrial septal defect (ASD) is a prevalent congenital heart condition in adults that leads to pulmonary hypertension (PAH) and right heart failure if left untreated. During a routine follow-up of adult ASD-PAH patients, the suitability of shunt closure depends on the invasive right heart catheterization (RHC). Nevertheless, performing RHC at every follow-up is impractical and may be harmful. The present retrospective cross-sectional study was designed to investigate which echocardiographic variables were associated with pulmonary vascular resistance (PVR) in adult ASD-PAH patients and propose a model using these variables to screen for patients with a correctable shunt.

Methods: A total of 530 adult ASD-PAH patients with pulmonary arterial systolic pressure (PASP) of ≥60 mmHg measured using transthoracic echocardiogram (TTE) were included in the study. All RHCs were performed within 3 months after TTE. The correctable shunt was defined as PVR ≤3 Wood units (WU). Multivariable regressions were performed utilizing echocardiographic variables. A scoring system was constructed based on the predictors of PVR ≤3 WU using multivariable logistic regression analysis. The scoring system was then examined using a receiver operating characteristic (ROC) analysis. In addition, clinical utility of the model was determined based on decision curve analysis, and a calibration curve was used to evaluate model conformity.

Results: Estimated PASP, velocity through the pulmonary valve, tricuspid annulus early diastolic velocity, and maximum defect dimension were identified as independent predictors. The area under the ROC curve of the predictive value in the model was 0.905 (95% CI, 0.878-0.931, sensitivity: 84.3%, specificity: 83.6%). The net benefit of the model was notable in terms of a wide-range probability threshold in decision curve analysis, indicating that the prediction model had good clinical applicability. The model's calibration curve was close to an ideal diagonal line, showing good predictive accuracy between the actual and predictive probabilities.

Conclusion: The study provided a valuable model in predicting adult ASD-PAH patients with a correctable shunt, which may help clinicians to make appropriate treatment decision for follow-up patients.

背景:房间隔缺损(ASD)是成人中常见的先天性心脏病,如不及时治疗会导致肺动脉高压(PAH)和右心衰竭。在对成人 ASD-PAH 患者进行常规随访时,分流关闭是否合适取决于有创的右心导管检查(RHC)。本回顾性横断面研究旨在调查哪些超声心动图变量与成人 ASD-PAH 患者的肺血管阻力(PVR)有关,并提出一个利用这些变量筛查可矫正分流患者的模型:研究共纳入了530例经胸超声心动图(TTE)测量肺动脉收缩压(PASP)≥60 mmHg的成人ASD-PAH患者。所有 RHC 均在 TTE 后 3 个月内进行。可纠正分流的定义是 PVR≤3 木单位(WU)。利用超声心动图变量进行多变量回归。通过多变量逻辑回归分析,根据 PVR ≤3 WU 的预测因素构建了一个评分系统。然后使用接收者操作特征(ROC)分析对评分系统进行了检验。此外,还根据决策曲线分析确定了模型的临床实用性,并使用校准曲线评估了模型的一致性:结果:估计的肺动脉收缩压、通过肺动脉瓣的速度、三尖瓣环早期舒张速度和最大缺损尺寸被确定为独立的预测因子。模型预测值的 ROC 曲线下面积为 0.905 [95%置信区间 (CI):0.878-0.931,敏感性:84.3%,特异性:83.6%]。在决策曲线分析中,该模型的净效益显著,概率阈值范围较宽,表明该预测模型具有良好的临床适用性。模型的校准曲线接近理想的对角线,显示出实际概率与预测概率之间良好的预测准确性:研究结果表明,该模型在预测可纠正分流的成人 ASD-PAH 患者方面具有重要价值,有助于临床医生为随访患者做出适当的治疗决策。
{"title":"A prediction model of echocardiographic variables to screen for potentially correctable shunts in adult atrial septal defect-pulmonary hypertension patients.","authors":"He-Zhi Li, Song Wen, Ze-Han Huang, Hong-Wen Fei, Cao-Jin Zhang","doi":"10.1097/JCMA.0000000000001190","DOIUrl":"10.1097/JCMA.0000000000001190","url":null,"abstract":"<p><strong>Background: </strong>Atrial septal defect (ASD) is a prevalent congenital heart condition in adults that leads to pulmonary hypertension (PAH) and right heart failure if left untreated. During a routine follow-up of adult ASD-PAH patients, the suitability of shunt closure depends on the invasive right heart catheterization (RHC). Nevertheless, performing RHC at every follow-up is impractical and may be harmful. The present retrospective cross-sectional study was designed to investigate which echocardiographic variables were associated with pulmonary vascular resistance (PVR) in adult ASD-PAH patients and propose a model using these variables to screen for patients with a correctable shunt.</p><p><strong>Methods: </strong>A total of 530 adult ASD-PAH patients with pulmonary arterial systolic pressure (PASP) of ≥60 mmHg measured using transthoracic echocardiogram (TTE) were included in the study. All RHCs were performed within 3 months after TTE. The correctable shunt was defined as PVR ≤3 Wood units (WU). Multivariable regressions were performed utilizing echocardiographic variables. A scoring system was constructed based on the predictors of PVR ≤3 WU using multivariable logistic regression analysis. The scoring system was then examined using a receiver operating characteristic (ROC) analysis. In addition, clinical utility of the model was determined based on decision curve analysis, and a calibration curve was used to evaluate model conformity.</p><p><strong>Results: </strong>Estimated PASP, velocity through the pulmonary valve, tricuspid annulus early diastolic velocity, and maximum defect dimension were identified as independent predictors. The area under the ROC curve of the predictive value in the model was 0.905 (95% CI, 0.878-0.931, sensitivity: 84.3%, specificity: 83.6%). The net benefit of the model was notable in terms of a wide-range probability threshold in decision curve analysis, indicating that the prediction model had good clinical applicability. The model's calibration curve was close to an ideal diagonal line, showing good predictive accuracy between the actual and predictive probabilities.</p><p><strong>Conclusion: </strong>The study provided a valuable model in predicting adult ASD-PAH patients with a correctable shunt, which may help clinicians to make appropriate treatment decision for follow-up patients.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"71-79"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between tooth loss, denture use, and dementia in older Taiwanese adults. 台湾老年人牙齿脱落、假牙使用与痴呆的关系。
Pub Date : 2025-01-01 Epub Date: 2024-09-20 DOI: 10.1097/JCMA.0000000000001171
Yi-Wen Chen, Chung-Yi Li, Shang-Chi Lee, Li-Jung Elizabeth Ku, Yu-Tsung Chou, Arief Hargono, Chang-Ta Chiu, Wen-Hsuan Hou

Background: The literature has mainly focused on the association between tooth loss and dementia, and evidence regarding the separate and joint effects of tooth loss and denture use on the risk of dementia is limited. This study investigated the links among tooth loss, denture use, and dementia risk in Taiwanese adults aged 65 years or older.

Methods: This retrospective cohort study utilized data from the 2009 National Health Interview Survey and 2008-2017 National Health Insurance claim records, including the records of 2247 individuals free from dementia treatment in 2008-2009. Dementia diagnoses were tracked until 2017. The Cox proportional hazards model was used to calculate hazard ratios (HRs) for exploring the correlations among tooth loss, denture use, and dementia risk.

Results: Older adults with 20 or more natural teeth and dentures had the lowest dementia incidence (1.43 per 100 person-years). Those with <20 natural teeth, with or without dentures, experienced high dementia incidence rates of 2.31 and 3.33 per 100 person-years, respectively. After adjusting for various factors (i.e., sociodemographic characteristics, health conditions/comorbidities, and lifestyles), having <20 natural teeth or not using dentures was associated with non-significantly increased HRs of 1.30 (95% CI, 0.99-1.71) and 1.20 (95% CI, 0.95-1.52). Subgroup analysis revealed that compared to older adults with 20 or more natural teeth and dentures, those with <20 natural teeth and not wearing dentures had a significantly increased risk of dementia (adjusted HR, 1.57; 95% CI, 1.04-2.37).

Conclusion: This study found that having <20 natural teeth and not using dentures was significantly associated with an increased risk of dementia in Taiwanese individuals aged 65 years or above.

背景:文献主要集中在牙齿脱落和痴呆之间的关系,关于牙齿脱落和义齿使用对痴呆风险的单独或联合影响的证据有限。摘要本研究调查台湾65岁以上老年人牙齿缺失、假牙使用与失智风险的关系。方法:本回顾性队列研究利用2009年全国健康访谈调查和2008-2017年国民健康保险索赔记录的数据,包括2008-2009年未接受痴呆治疗的2247人的记录。痴呆症诊断一直追踪到2017年。采用Cox比例风险模型计算风险比(hr),探讨牙齿脱落、义齿使用与痴呆风险之间的相关性。结果:拥有20颗或更多天然牙和假牙的老年人痴呆发病率最低(1.43 / 100人年)。结论:这项研究发现拥有
{"title":"Associations between tooth loss, denture use, and dementia in older Taiwanese adults.","authors":"Yi-Wen Chen, Chung-Yi Li, Shang-Chi Lee, Li-Jung Elizabeth Ku, Yu-Tsung Chou, Arief Hargono, Chang-Ta Chiu, Wen-Hsuan Hou","doi":"10.1097/JCMA.0000000000001171","DOIUrl":"10.1097/JCMA.0000000000001171","url":null,"abstract":"<p><strong>Background: </strong>The literature has mainly focused on the association between tooth loss and dementia, and evidence regarding the separate and joint effects of tooth loss and denture use on the risk of dementia is limited. This study investigated the links among tooth loss, denture use, and dementia risk in Taiwanese adults aged 65 years or older.</p><p><strong>Methods: </strong>This retrospective cohort study utilized data from the 2009 National Health Interview Survey and 2008-2017 National Health Insurance claim records, including the records of 2247 individuals free from dementia treatment in 2008-2009. Dementia diagnoses were tracked until 2017. The Cox proportional hazards model was used to calculate hazard ratios (HRs) for exploring the correlations among tooth loss, denture use, and dementia risk.</p><p><strong>Results: </strong>Older adults with 20 or more natural teeth and dentures had the lowest dementia incidence (1.43 per 100 person-years). Those with <20 natural teeth, with or without dentures, experienced high dementia incidence rates of 2.31 and 3.33 per 100 person-years, respectively. After adjusting for various factors (i.e., sociodemographic characteristics, health conditions/comorbidities, and lifestyles), having <20 natural teeth or not using dentures was associated with non-significantly increased HRs of 1.30 (95% CI, 0.99-1.71) and 1.20 (95% CI, 0.95-1.52). Subgroup analysis revealed that compared to older adults with 20 or more natural teeth and dentures, those with <20 natural teeth and not wearing dentures had a significantly increased risk of dementia (adjusted HR, 1.57; 95% CI, 1.04-2.37).</p><p><strong>Conclusion: </strong>This study found that having <20 natural teeth and not using dentures was significantly associated with an increased risk of dementia in Taiwanese individuals aged 65 years or above.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":"88 1","pages":"43-51"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of attitudes toward and experiences with traditional Chinese medicines among people in Taiwan. 台湾民众对传统中药的态度和体验调查。
Pub Date : 2025-01-01 Epub Date: 2024-10-21 DOI: 10.1097/JCMA.0000000000001181
Cheng-Yu Chuang, Hui-Yu Chung, Fu-Shih Chen, Ichiro Arai

Background: Despite numerous surveys on traditional Chinese medicines (TCMs) and their impact on people in Taiwan, only a few directly assessed the perspectives of the users and their experiences with the practice. In this study, we aimed to explore the attitudes, experiences, and understanding of TCMs, and also to identify the TCMs that are commonly preferred among people in Taiwan.

Methods: We conducted an online survey among people in Taiwan to reflect the viewpoints of the general public on TCMs in 2022. Individuals working in the medical field were excluded. Question topics included experience, impressions, access, and expectations.

Results: According to the results of the questionnaire survey, of the 518 participants interviewed, more than 95% had used TCMs. "Work gently" was the most common positive impression, and "Take effect slowly" was the most common negative impression. Among the over-the-counter TCMs that were taken by the participants, "Si Wu Tang," which tends to be used for treating female diseases, was the most common. The main expectations for TCMs were to improve daily health and prevent diseases. Although the participants were well informed about TCMs, there was still room for improvement. For example, 30% of the participants still did not know that TCMs might have side effects.

Conclusion: People in Taiwan who participated in the survey had a relatively positive impression of and experience with TCMs, but there were still some knowledge gaps that need to be filled with additional information. It is essential to strengthen the publicity and education about TCMs and improve the public's understanding and correct use of TCMs.

背景:尽管有许多关于传统中药及其对台湾民众影响的调查,但只有少数调查直接评估了使用者的观点及其使用传统中药的经验。在这项研究中,我们旨在探讨台湾民众对中药的态度、体验和理解,并找出台湾民众普遍偏爱的中药:方法:我们对台湾民众进行了一次在线调查,以反映 2022 年台湾民众对中医药的看法。不包括医疗相关人员。问题主题包括经验、印象、获取途径和期望:共有 518 人参与调查。结果:共有 518 人参与调查,其中 95% 以上的人服用过中药。"温和 "是最常见的正面印象,"起效慢 "是最常见的负面印象。在参与者服用过的非处方中药中,用于治疗女性疾病的 "四物汤 "最为常见。对中药的主要期望是帮助改善日常健康和预防疾病。虽然参与者对中医药的认识很高,但仍有改进的余地。例如,仍有 30% 的参与者不知道中药可能有副作用:结论:参与调查的台湾民众对中药的印象和体验相对较好,但仍有一些认知盲点需要填补。加强中药的宣传教育,提高民众对中药的认识和正确使用是十分必要的。
{"title":"A survey of attitudes toward and experiences with traditional Chinese medicines among people in Taiwan.","authors":"Cheng-Yu Chuang, Hui-Yu Chung, Fu-Shih Chen, Ichiro Arai","doi":"10.1097/JCMA.0000000000001181","DOIUrl":"10.1097/JCMA.0000000000001181","url":null,"abstract":"<p><strong>Background: </strong>Despite numerous surveys on traditional Chinese medicines (TCMs) and their impact on people in Taiwan, only a few directly assessed the perspectives of the users and their experiences with the practice. In this study, we aimed to explore the attitudes, experiences, and understanding of TCMs, and also to identify the TCMs that are commonly preferred among people in Taiwan.</p><p><strong>Methods: </strong>We conducted an online survey among people in Taiwan to reflect the viewpoints of the general public on TCMs in 2022. Individuals working in the medical field were excluded. Question topics included experience, impressions, access, and expectations.</p><p><strong>Results: </strong>According to the results of the questionnaire survey, of the 518 participants interviewed, more than 95% had used TCMs. \"Work gently\" was the most common positive impression, and \"Take effect slowly\" was the most common negative impression. Among the over-the-counter TCMs that were taken by the participants, \"Si Wu Tang,\" which tends to be used for treating female diseases, was the most common. The main expectations for TCMs were to improve daily health and prevent diseases. Although the participants were well informed about TCMs, there was still room for improvement. For example, 30% of the participants still did not know that TCMs might have side effects.</p><p><strong>Conclusion: </strong>People in Taiwan who participated in the survey had a relatively positive impression of and experience with TCMs, but there were still some knowledge gaps that need to be filled with additional information. It is essential to strengthen the publicity and education about TCMs and improve the public's understanding and correct use of TCMs.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"34-42"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma. 高风险尤文肉瘤儿童和青少年患者的大剂量化疗与自体干细胞救治:台湾一家研究所的经验。
Pub Date : 2025-01-01 Epub Date: 2024-10-11 DOI: 10.1097/JCMA.0000000000001179
Chih-Ying Lee, Ming-Hsin Hou, Giun-Yi Hung, Cheng-Yin Ho, Ting-Yen Yu, Po-Kuei Wu, Chao-Ming Chen, Chueh-Chuan Yen, Cheng-Ying Shiau, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Ching-Lan Wu, Hsiu-Ju Yen, Wei-Ming Chen

Background: A combination treatment of surgery, chemotherapy, and radiotherapy can improve the survivals of pediatric patients with Ewing sarcoma (ES). However, prognosis remains poor for patients with metastatic disease at diagnosis or recurrence. Other high-risk (HR) features include large tumor burden, tumors of the axial skeleton, and poor histologic response. Several studies have documented high-dose chemotherapy with autologous stem cell rescue (HDC-ASCR) to be effective in such patients. In this retrospective study, we present the results of HDC-ASCR for high-risk ES (HRES) in children and young adults in a single institute.

Methods: From March 2004 to March 2021, patients with ES, Ewing-like sarcoma, or round cell sarcoma received HDC-ASCR as part of treatment were included. The patients' characteristics, disease status, stem cell dose, engraftment status, post-transplant complications, and outcomes were analyzed.

Results: Twenty patients receiving HDC-ASCR at complete response (n = 6), partial response (n = 13), and stable disease (n = 1) were enrolled. The male-to-female ratio was 11:9. Median age at diagnosis and transplant was 15.6 years old (range: 3.3-28.9) and 16.2 (range: 4.2-29.9), respectively. The conditioning regimens included ifosfamide-based in two and melphalan-based in 19. All patients achieved successful engraftment without transplant-related mortality. The 5-year progression-free and overall survival (OS) rate were 35% and 54.5%, respectively. The causes of death (n = 8) were all contributed to disease progression. Patients in the complete response group or with localized HRES exhibited a higher 5-year OS ( p = 0.047 and 0.05, respectively). Compared with the historical cohort without HDC-ASCR as part of primary treatment, the current cohort had a significantly better 5-year OS ( p = 0.018).

Conclusion: HDC-ASCR seems promising as an alternative treatment for HRES in improving OS in this retrospective study with a limited case number.

背景:手术、化疗和放疗的综合治疗可提高儿童尤文肉瘤(ES)患者的存活率。然而,确诊时有转移性疾病或复发的患者预后仍然很差。其他高危(HR)特征包括肿瘤负荷大、肿瘤位于轴状骨骼和组织学反应差。多项研究表明,大剂量化疗联合自体干细胞救治(HDC-ASCR)对此类患者有效。在这项回顾性研究中,我们介绍了一家研究所采用HDC-ASCR治疗高危儿童和年轻成人尤文肉瘤的结果:方法:纳入 2004 年 3 月至 2021 年 3 月期间接受 HDC-ASCR 治疗的 ES、尤文样肉瘤或圆形细胞肉瘤患者。分析了患者的特征、疾病状态、干细胞剂量、移植状态、移植后并发症和预后:20名患者在完全反应(6人)、部分反应(13人)和病情稳定(1人)时接受了HDC-ASCR治疗。男女比例为 11:9。诊断和移植时的中位年龄分别为 15.6 岁(范围:3.3-28.9)和 16.2 岁(范围:4.2-29.9)。2名患者采用了伊福酰胺治疗方案,19名患者采用了美法仑治疗方案。所有患者都成功实现了移植,且无坦杉相关死亡率。5年无进展生存率和总生存率(OS)分别为35%和54.5%。死亡原因(8 例)均与疾病进展有关。完全应答组或局部HRES患者的5年生存率较高(P = 0.047和0.05)。与未将HDC-ASCR作为主要治疗手段的历史队列相比,当前队列的5年OS明显更好(p = 0.018):结论:在这项病例数有限的回顾性研究中,HDC-ASCR似乎有望作为HRES的替代治疗方法,改善患者的OS。
{"title":"High-dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma.","authors":"Chih-Ying Lee, Ming-Hsin Hou, Giun-Yi Hung, Cheng-Yin Ho, Ting-Yen Yu, Po-Kuei Wu, Chao-Ming Chen, Chueh-Chuan Yen, Cheng-Ying Shiau, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Ching-Lan Wu, Hsiu-Ju Yen, Wei-Ming Chen","doi":"10.1097/JCMA.0000000000001179","DOIUrl":"10.1097/JCMA.0000000000001179","url":null,"abstract":"<p><strong>Background: </strong>A combination treatment of surgery, chemotherapy, and radiotherapy can improve the survivals of pediatric patients with Ewing sarcoma (ES). However, prognosis remains poor for patients with metastatic disease at diagnosis or recurrence. Other high-risk (HR) features include large tumor burden, tumors of the axial skeleton, and poor histologic response. Several studies have documented high-dose chemotherapy with autologous stem cell rescue (HDC-ASCR) to be effective in such patients. In this retrospective study, we present the results of HDC-ASCR for high-risk ES (HRES) in children and young adults in a single institute.</p><p><strong>Methods: </strong>From March 2004 to March 2021, patients with ES, Ewing-like sarcoma, or round cell sarcoma received HDC-ASCR as part of treatment were included. The patients' characteristics, disease status, stem cell dose, engraftment status, post-transplant complications, and outcomes were analyzed.</p><p><strong>Results: </strong>Twenty patients receiving HDC-ASCR at complete response (n = 6), partial response (n = 13), and stable disease (n = 1) were enrolled. The male-to-female ratio was 11:9. Median age at diagnosis and transplant was 15.6 years old (range: 3.3-28.9) and 16.2 (range: 4.2-29.9), respectively. The conditioning regimens included ifosfamide-based in two and melphalan-based in 19. All patients achieved successful engraftment without transplant-related mortality. The 5-year progression-free and overall survival (OS) rate were 35% and 54.5%, respectively. The causes of death (n = 8) were all contributed to disease progression. Patients in the complete response group or with localized HRES exhibited a higher 5-year OS ( p = 0.047 and 0.05, respectively). Compared with the historical cohort without HDC-ASCR as part of primary treatment, the current cohort had a significantly better 5-year OS ( p = 0.018).</p><p><strong>Conclusion: </strong>HDC-ASCR seems promising as an alternative treatment for HRES in improving OS in this retrospective study with a limited case number.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"85-91"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection of the apposite vacuum extractor during operative delivery: A biomechanical study. 在手术分娩过程中选择合适的真空提取器:一项生物力学研究。
Pub Date : 2024-12-30 DOI: 10.1097/JCMA.0000000000001204
Ping-Lin Hsieh, Peng-Hui Wang, Jyun-Cheng Ke, Kai-Jo Chiang, Chi-Kang Lin, Fung-Wei Chang, Kuo-Min Su, Kuo-Chih Su

Background: Operative delivery is a technique used during vaginal or cesarean birth to facilitate the patient's labor course through the assistance of a vacuum extractor. This method is increasingly used compared with forceps. This study aimed to investigate the forced effects of vacuum extractors comprising vacuum cups with different thicknesses on the fetal head and the vacuum extractor during vacuum-assisted delivery and to determine the optimal thickness for reducing the failure rate and minimizing neonatal and maternal morbidity.

Methods: A biomechanical model was developed to examine the impact of vacuum cups with varying thicknesses. This simulation three-dimensional (3D) geometry model was used to evaluate hemispherical-shaped vacuum extractors made of silicone rubber having a similar cup diameter of 70 mm with varying thicknesses (1 mm to 5 mm), which were applied to the three models (flat surfaces, hemispherical balls, and fetal head). Under one boundary condition and two different loading conditions, finite element analysis was utilized to simulate the force of vacuum extractors on the fetal head during the process of operative delivery. The main observation indicators were the reaction forces of the constructed model, and von Mises stress on both the vacuum extractors and fetal head.

Results: For the reaction forces on each axis, we found that the sum of the reaction force values on each axis was increased as the thickness of the vacuum extractor was increased, regardless of the surface type. Additionally, the reaction force of the fixed-support end was increased with the increased thickness of the vacuum extractor. The von Mises stress distributions of vacuum extractors comprising vacuum cups with different thicknesses, revealed that the thinner the cup, the greater the von Mises stress exerted on the extractor itself regardless of the surface type. The distribution of von Mises stress on the skull structure of the fetal head, showed that the thinner the cup, the greater the von Mises stress exerted on the skull structure regardless of the surface type.

Conclusion: A thinner vacuum extractor cup may result in greater injury to the fetus; hence, a thicker vacuum extractor cup is preferably utilized during vacuum-assisted operative delivery. Using a thicker vacuum extractor should yield a higher successful delivery rate and reduce fetal injury.

背景:手术分娩是一种在阴道或剖宫产过程中使用的技术,通过真空抽吸器的辅助来促进患者的分娩过程。与钳子相比,这种方法越来越多地被使用。本研究旨在探讨不同厚度的真空吸盘在真空辅助分娩过程中对胎儿头部和真空吸盘的强迫作用,并确定最佳厚度以降低失败率,最大限度地降低新生儿和产妇的发病率。方法:建立生物力学模型,研究不同厚度的真空杯对人体的影响。该仿真三维几何模型应用于三种模型(平面、半球形球和胎头)上,对杯径为70 mm的硅橡胶半球形真空抽提器进行了评价,该半球形真空抽提器具有不同的厚度(1 mm至5 mm)。在一种边界条件和两种不同载荷条件下,采用有限元方法模拟了真空抽吸器在手术分娩过程中对胎儿头部的作用力。主要观察指标为所构建模型的反作用力,以及真空抽吸器和胎头的von Mises应力。结果:对于各轴上的反作用力,我们发现,无论表面类型如何,各轴上的反作用力值之和都随着真空抽提器厚度的增加而增加。固支端反力随抽吸器厚度的增加而增大。由不同厚度的真空吸盘组成的真空吸盘的von Mises应力分布表明,无论表面类型如何,吸盘越薄,施加在吸盘上的von Mises应力越大。von Mises应力在胎头颅骨结构上的分布表明,无论表面类型如何,杯子越薄,对颅骨结构施加的von Mises应力越大。结论:真空抽采杯越薄,对胎儿的伤害越大;因此,在真空辅助手术分娩时,最好使用较厚的真空抽吸杯。使用较厚的真空抽吸器可以提高分娩成功率,减少胎儿损伤。
{"title":"Selection of the apposite vacuum extractor during operative delivery: A biomechanical study.","authors":"Ping-Lin Hsieh, Peng-Hui Wang, Jyun-Cheng Ke, Kai-Jo Chiang, Chi-Kang Lin, Fung-Wei Chang, Kuo-Min Su, Kuo-Chih Su","doi":"10.1097/JCMA.0000000000001204","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001204","url":null,"abstract":"<p><strong>Background: </strong>Operative delivery is a technique used during vaginal or cesarean birth to facilitate the patient's labor course through the assistance of a vacuum extractor. This method is increasingly used compared with forceps. This study aimed to investigate the forced effects of vacuum extractors comprising vacuum cups with different thicknesses on the fetal head and the vacuum extractor during vacuum-assisted delivery and to determine the optimal thickness for reducing the failure rate and minimizing neonatal and maternal morbidity.</p><p><strong>Methods: </strong>A biomechanical model was developed to examine the impact of vacuum cups with varying thicknesses. This simulation three-dimensional (3D) geometry model was used to evaluate hemispherical-shaped vacuum extractors made of silicone rubber having a similar cup diameter of 70 mm with varying thicknesses (1 mm to 5 mm), which were applied to the three models (flat surfaces, hemispherical balls, and fetal head). Under one boundary condition and two different loading conditions, finite element analysis was utilized to simulate the force of vacuum extractors on the fetal head during the process of operative delivery. The main observation indicators were the reaction forces of the constructed model, and von Mises stress on both the vacuum extractors and fetal head.</p><p><strong>Results: </strong>For the reaction forces on each axis, we found that the sum of the reaction force values on each axis was increased as the thickness of the vacuum extractor was increased, regardless of the surface type. Additionally, the reaction force of the fixed-support end was increased with the increased thickness of the vacuum extractor. The von Mises stress distributions of vacuum extractors comprising vacuum cups with different thicknesses, revealed that the thinner the cup, the greater the von Mises stress exerted on the extractor itself regardless of the surface type. The distribution of von Mises stress on the skull structure of the fetal head, showed that the thinner the cup, the greater the von Mises stress exerted on the skull structure regardless of the surface type.</p><p><strong>Conclusion: </strong>A thinner vacuum extractor cup may result in greater injury to the fetus; hence, a thicker vacuum extractor cup is preferably utilized during vacuum-assisted operative delivery. Using a thicker vacuum extractor should yield a higher successful delivery rate and reduce fetal injury.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Chinese Medical Association : JCMA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1